Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 121147
Published online Aug 27, 2026. doi: 10.4240/wjgs.121147
Published online Aug 27, 2026. doi: 10.4240/wjgs.121147
Table 1 Comparison of surgical, endoscopic, and magnetic compression approaches
| Parameter | Surgical repair | Endoscopic/stenting | MCA |
| Invasiveness | High (open/laparoscopic) | Low-moderate (endoscopic) | Low-moderate (minimally invasive) |
| Immediate success rate | High (but not 100%) | Variable (depends on anatomy) | High (in selected cases) |
| Need for re-intervention | Moderate (strictures can recur) | High (stents need exchange, recurrent strictures) | Moderate (requires dilation and stenting post-MCA) |
| Technical difficulty | High (surgery/anastomosis) | Moderate (ERCP/PTBD) | High (new technique, device handling) |
| Patient risk | High (operative risk) | Low-moderate (infection, pancreatitis) | Low (mostly sedation/endoscopy risks) |
| Evidence base | Strong | Strong (RCTs, meta-analyses) | Weak (case series, early reports) |
Table 2 Summary of clinical studies evaluating magnetic compression anastomosis for biliary conditions
| Ref. | Country | Design and patients | Indication | Main outcome | Adverse events and limitations |
| Jang et al[35], 2011 | South Korea | Retrospective observational study; n = 12 | Biliary anastomotic strictures after living donor liver transplantation | Successful recanalization of biliary anastomotic stricture after LDLT. Clinical success: 9/12 (75%); technical success: 10/12 (83.3%) | Mild cholangitis (n = 1); recurrence of anastomotic stricture (n = 1) |
| Jang et al[36], 2014 | South Korea | Retrospective case series; n = 7 | Recanalization of refractory benign biliary strictures | Successful recanalization of completely obstructed benign biliary strictures. Clinical success: 5/7 (71.4%); technical success: 5/7 (71.4%) | No MCA-related complications or restenosis reported |
| Ersoz et al[37], 2016 | Turkey | Pilot study/case series; n = 6 | Disconnected bile duct after living-donor liver transplantation | Biliary recanalization after magnetic compression anastomosis. Clinical success: 6/6 (100%); technical success: 6/6 (100%) | No procedure-related adverse events reported |
| Jang et al[2], 2017 | South Korea | Single-center retrospective cohort study; n = 39 | Completely obstructed benign biliary strictures | Successful recanalization and long-term patency of the biliary tract. Clinical success: 33/39 (84.6%); technical success: 35/39 (89.7%) | Mild cholangitis (n = 1); restenosis (n = 1); partial restenosis (n = 1) |
| Parlak et al[21], 2017 | Turkey | Prospective case series; n = 9 | Complete biliary obstruction after liver transplantation | Recanalization of complete duct-to-duct biliary anastomosis obstruction. Clinical success: 7/9 (77.8%); technical success: 7/9 (77.8%) | No procedure-related adverse events |
| Li et al[10], 2020 | China | Prospective single-center clinical study; n = 9 | Benign biliary strictures | Successful recanalization of benign biliary stricture with sustained duct patency. Clinical success: 9/9 (100%); technical success: 9/9 (100%) | Mild cholangitis (n = 1); biliary bleeding from PTBD tract (n = 1) |
| Ödemiş et al[12], 2022 | Turkey | Retrospective case series; n = 19 | Completely obstructed benign biliary strictures | Recanalization of completely obstructed benign biliary strictures with restoration of bile flow. Clinical success: 12/19 (63.2%); technical success: 19/21 procedures (90.5%) | Magnet entrapment (n = 3); magnet migration (n = 2); cholangitis (n = 1) |
| Chavan et al[38], 2024 | India | Case series; n = 3 | Post-cholecystectomy benign biliary stricture recanalization | Bile duct recanalization confirmed by cholangiography after magnet removal. Clinical success: 3/3 (100%); technical success: 3/3 (100%) | None reported |
| Jang et al[39], 2024 | South Korea | Retrospective cohort study; n = 10 | Complete biliary obstruction after cholecystectomy | Recanalization of complete biliary obstruction with creation of a fistulous tract. Clinical success: 8/10 (80%); technical success: 10/10 (100%) | No procedure-related adverse events; 2 patients developed stricture recurrence treated with repeat FCSEMS |
| Ünal et al[40], 2025 | Turkey | Retrospective single-center cohort study; n = 26 | Post-transplant biliary strictures (combined endoscopic-percutaneous approach) | Successful recanalization of completely obstructed post-transplant biliary anastomotic strictures with long-term patency. Clinical success: 24/26 (92.3%); technical success: 24/26 (92.3%) | Recurrent biliary stricture during follow-up (n = 6); no major procedure-related complications reported |
Table 3 Summary of clinical studies evaluating magnetic compression anastomosis for biliary-enteric conditions
| Ref. | Country | Design and patients | Indication | Main outcome | Adverse events and limitations |
| Liu et al[41], 2018 | China | Prospective clinical trial; n = 41 | Biliojejunostomy | Successful formation of bilioenteric anastomosis with long-term patency. Clinical success: 39/41 (95.1%); technical success: 41/41 (100%) | Cholangitis before magnet expulsion (n = 3); biliary anastomotic stricture requiring reoperation (n = 2) |
| Liu et al[42], 2019 | China | Prospective case series; n = 5 | Laparoscopic magnetic compression biliojejunostomy for obstructive jaundice | Formation of patent biliojejunostomy with successful internal biliary drainage. Clinical success: 5/5 (100%); technical success: 5/5 (100%) | Wound infection (n = 1); no anastomotic leak or stricture |
| Liu et al[43], 2019 | China | Prospective case series; n = 4 | Biliojejunostomy and pancreaticojejunostomy during Whipple’s procedure | Formation of functional biliojejunostomy and pancreaticojejunostomy after pancreaticoduodenectomy. Clinical success: 3/4 (75%); technical success: 4/4 (100%) | Cholangitis (n = 1); pancreatic fistula (n = 1); biliary anastomotic stricture at 11 months (n = 1) |
| Li et al[44], 2021 | China | Retrospective case series; n = 7 | Magnetic compression anastomosis during laparoscopic pancreatoduodenectomy for choledochojejunostomy and pancreatojejunostomy | Formation and postoperative function of magnetic biliojejunostomy and pancreaticojejunostomy after laparoscopic pancreatoduodenectomy. Clinical success: 7/7 (100%); technical success: 7/7 (100%) | Pancreatic fistula (n = 2); intra-abdominal infection (n = 2); delayed gastric emptying (n = 2); intra-abdominal bleeding (n = 1); no biliary or pancreatic anastomotic leak |
| Li et al[45], 2021 | China | Prospective clinical study; n = 23 | Cholangiojejunostomy | Restoration of biliary drainage through magnetic compression cholangiojejunostomy. Clinical success: 22/23 (95.7%); technical success: 23/23 (100%) | Bile leakage (n = 1); postoperative complications (Clavien-Dindo I-IIIa) in 10 patients; cholangitis during follow-up (n = 3); anastomotic stricture (n = 1) |
| Avaliani et al[46], 2009 | Russia | Prospective clinical series; n = 34 | Palliation of malignant obstructive jaundice | Creation of biliary-enteric fistula for internal biliary drainage in malignant obstructive jaundice. Clinical success: 29/34 (85.3%); technical success: 34/34 (100%) | Temporary occlusion of bypass due to food debris (n = 2); tumor ingrowth requiring surgical revision (n = 3); reflux cholangitis (n = 2) |
Table 4 Summary of clinical studies evaluating magnetic compression anastomosis for esophageal conditions
| Ref. | Country | Design and patients | Indication | Main outcome | Adverse events and limitations |
| Zaritzky et al[47], 2009 | Argentina | Prospective; n = 5 | Esophageal atresia | Successful formation of an esophageal anastomosis. Clinical success: 100%; technical success: 80% | Restenosis in 80% requiring dilatation and Fever in one patient |
| Slater et al[50], 2019 | United States | Multicenter retrospective case series; n = 13 | Long-gap esophageal atresia | Establishment of esophageal continuity and long-term preservation of native esophagus. Clinical success: 12/13 (92.3%); technical success: 13/13 (100%) | Esophageal stricture requiring dilation in all patients (mean 9.8 dilations); stent placement (n = 6); surgery for refractory stricture (n = 2); perforation after dilation (n = 1) |
| Shieh et al[51], 2022 | United States | Retrospective case series; n = 3 | Long-gap esophageal atresia | Establishment of esophageal continuity and long-term. Clinical success: 0/3 (0%); technical success: 3/3 (100%) | Failure of anastomosis in 2 patients; magnet erosion into lung requiring surgery (n = 1); severe anastomotic stricture after repeat magnamosis (n = 1) |
| Conforti et al[52], 2023 | Italy | Case series; n = 5 | Long-gap esophageal atresia | Restoration of esophageal continuity. Clinical success: 5/5 (100%); technical success: 5/5 (100%) | Anastomotic stenosis requiring dilation (5/5); esophageal perforation after dilation (n = 1) |
| Lee et al[53], 2024 | Germany, United States | First-in-human case series; n = 10 | Esophageal magnetic compression anastomosis using the connect-EA device for esophageal atresia repair | Restoration of esophageal continuity and tolerance of oral feeding. Clinical success: 7/10 (70%); technical success: 9/10 (90%) | Bronchoesophageal fistula (n = 1); esophageal perforation after balloon dilation (n = 2) |
Table 5 Summary of clinical studies evaluating magnetic compression anastomosis for intestinal and colorectal conditions
| Ref. | Country | Design and patients | Indication | Main outcome | Adverse events and limitations |
| Graves et al[13], 2017 | United States | Prospective single-center first-in-human pilot study; n = 5 | Small bowel anastomosis during open reconstructive surgery | Formation of functional small bowel anastomosis without leak, bleeding, or stricture. Clinical success: 5/5 (100%); technical success: 5/5 (100%) | No anastomosis-related complications; unrelated complications included aspiration pneumonia, internal hernia, Clostridium difficile infection, and superficial surgical site infection |
| Kamada et al[63], 2021 | Japan | Retrospective single-center case series; n = 14 | Gastrointestinal obstruction (without general anesthesia) | Creation of functional gastrointestinal anastomosis to relieve obstruction. Clinical success: 11/14 (78.6%); technical success: 14/14 (100%) | Restenosis (n = 2); anastomotic perforation due to balloon dilation (n = 1) |
| Gagner et al[64], 2023 | Georgia | Prospective first-in-human observational study; n = 5 | Side-to-side magnetic compression duodeno-ileostomy with sleeve gastrectomy for obesity and type 2 diabetes | Successful creation of patent duodeno-ileal anastomosis with magnet expulsion without reintervention. Clinical success: 5/5 (100%); technical success: 5/5 (100%) | No device-related adverse events; mild abdominal wound pain (n = 3), mucosal tear during endoscopy (n = 1), intra-abdominal hematoma (n = 1), ileal serosal tear (n = 1) |
| Gagner et al[65], 2023 | Belgium, Spain, Georgia | Prospective multicenter observational study; n = 24 | Side-to-side magnetic duodeno-ileostomy with sleeve gastrectomy for obesity and type 2 diabetes | Successful magnet placement with formation of patent duodeno-ileal anastomosis and spontaneous magnet expulsion. Clinical success: 24/24 (100%); technical success: 24/24 (100%) | 3 procedure-related serious adverse events; no device-related adverse events, no anastomotic leak, bleeding, obstruction, infection, or mortality |
| Cadière et al[66], 2024 | Belgium | Prospective observational study; n = 10 | Side-to-side duodeno-ileal bipartition with sleeve gastrectomy | Patent duodeno-ileal anastomosis confirmed endoscopically at 1 year. Clinical success: 9/9 evaluated (100%); technical success: 10/10 (100%) | Serosal tears (n = 2), sleeve leak (n = 1), dehydration (n = 3), internal hernia (n = 1); no device-related AEs |
| Gagner et al[22], 2025 | Canada, Belgium, Spain, Georgia | Prospective multicenter study; n = 43 | Side-to-side magnetic duodeno-ileostomy with or without sleeve gastrectomy for severe obesity | Successful magnet positioning, formation of patent duodeno-ileal anastomosis, and spontaneous magnet passage. Clinical success: 43/43 (100%); technical success: 43/43 (100%) | No device-related adverse events, leaks, bleeding, obstruction, infection, or death |
| Gagner et al[67], 2024 | Belgium | Prospective single-center study; n = 24 | Revisional side-to-side magnetic duodeno-ileostomy after sleeve gastrectomy for severe obesity | Formation of patent duodeno-ileal anastomosis with spontaneous magnet expulsion and no need for reintervention. Clinical success: 24/24 (100%); technical success: 24/24 (100%) | 8 SAEs (Clavien-Dindo II-III) but none related to device or procedure; no leak, bleeding, obstruction, infection, or death |
| Gagner et al[68], 2024 | Belgium | Prospective single-center first-in-human study; n = 7 | Gastroileostomy for revision of sleeve gastrectomy | Successful placement and alignment of magnets with patent gastroileal anastomosis and spontaneous magnet expulsion. Clinical success: 7/7 (100%); technical success: 7/7 (100%) | 3 serious adverse events (Clavien-Dindo III anal fissure/hemorrhoids in 1 patient); no device-related adverse events, leaks, bleeding, obstruction, infection, or death |
| Gagner et al[69], 2025 | Czech Republic | Prospective first-in-human observational study; n = 9 | Jejuno-ileostomy bipartition for obesity and type 2 diabetes | Successful magnet alignment and formation of patent jejuno-ileal anastomosis with spontaneous magnet expulsion. Clinical success: 9/9 (100%); technical success: 9/9 (100%) | No severe adverse events; minor events included influenza after discharge and transient hypoglycemia after magnet expulsion |
| Bhandari et al[70], 2026 | India, Chile | Prospective multicenter study; n = 14 | Jejuno-jejunal anastomosis in Roux-en-Y gastric bypass | Freedom from anastomotic adverse events within 30 days. Clinical success: 14/14 (100%); technical success: 14/14 (100%) | Procedure-related AEs: Bleeding, dysphagia, pulmonary embolism, diabetic ketoacidosis (n = 4); no device-related AEs |
| Machytka et al[57], 2017 | Czech Republic | Prospective single center study; n = 10 | Partial jejunal diversion | Total weight loss. Clinical success: 100%; technical success: 100% | No Serious, trocar-related gastric injury in one patient |
- Citation: Reddy RT, Bagrodia A, Mehta K, Vaithiyam V, Mohan SL, Sirohi N, Dalal A, Srivastava S, Sachdeva S. Magnetic compression anastomosis in gastrointestinal and biliary disease: Techniques and clinical applications. World J Gastrointest Surg 2026; 18(8): 121147
- URL: https://www.wjgnet.com/1948-9366/full/v18/i8/121147.htm
- DOI: https://dx.doi.org/10.4240/wjgs.121147